Delivery Order SPE2DB20D3304-SPE2DB24FW5G4
Award Date
2/13/24
Potential Completion Date
2/14/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $24,102.36 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GARDASIL 9 syringes. This delivery order falls under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, valued up to $999,999,999.00 with a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,616.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a $16,167.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Gardasil 9 syringes and has a completion date of February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $3,950.84 for the supply of GARDASIL 9 syringes. The contract has an ultimate completion date of April 12, 2024 and does not include any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp as a single award, with a potential value of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML. This $11,765.66 delivery order contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this contract, which is not set aside for any specific business type. This delivery order is part of a larger indefinite delivery contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML pharmaceutical products. The award is valued at $5,349.82 and has a completion date of January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31,...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order worth $9,535.20 to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for the supply of GARDASIL 9, a 0.5 ml syringe vaccine, with a period of performance through September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive...
The Defense Logistics Agency (DLA) awarded a $6,749.43 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GARDASIL 9 syringes. This delivery order has a completion date of March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to government agencies, particularly the Department of Defense. This delivery order is part...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $17,986.25 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide GARDASIL 9 SYRINGE 0.5ML. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,528.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GARDASIL 9 vaccine syringes. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp as the sole prime contractor, which serves as the primary vehicle for the company to provide a range of pharmaceutical...